Acute Stress Cardiomyopathy: Heart of pheochromocytoma.

[1]  H. Timmers,et al.  Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial , 2019, The Journal of clinical endocrinology and metabolism.

[2]  H. Falhammar,et al.  Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome , 2019, Endocrine.

[3]  Jeroen J. Bax,et al.  Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome. , 2019, Circulation.

[4]  S. Albert,et al.  Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature. , 2017, International journal of cardiology.

[5]  S. Mansour,et al.  TAKOTSUBO-LIKE CARDIOMYOPATHY IN A LARGE COHORT OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  J. Lenders,et al.  Update on Modern Management of Pheochromocytoma and Paraganglioma , 2017, Endocrinology and metabolism.

[7]  S. Y-Hassan.  Clinical Features and Outcome of Pheochromocytoma-Induced Takotsubo Syndrome: Analysis of 80 Published Cases. , 2016, The American journal of cardiology.

[8]  J. Lusson,et al.  Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses? , 2015, Medicine.

[9]  Jeroen J. Bax,et al.  Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. , 2015, The New England journal of medicine.

[10]  L. Amar,et al.  Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging , 2015, Clinical endocrinology.

[11]  S. Aylwin,et al.  Phaeochromocytoma crisis , 2014, Clinical endocrinology.

[12]  A. Hagège,et al.  Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma , 2013, Heart.

[13]  Q. Duh,et al.  Pheochromocytoma crisis is not a surgical emergency. , 2013, The Journal of clinical endocrinology and metabolism.

[14]  F. Messerli,et al.  Takotsubo-like cardiomyopathy in pheochromocytoma. , 2011, International journal of cardiology.

[15]  J. Lenders,et al.  Cardiovascular manifestations of phaeochromocytoma , 2011, Journal of hypertension.

[16]  A. Antonelli,et al.  Cardiovascular complications in patients with pheochromocytoma: a mini-review. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  K. Pacak,et al.  Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. , 2008, European journal of endocrinology.

[18]  C. Hamm,et al.  Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. , 2007, European heart journal.

[19]  E. Lonn,et al.  Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. , 2006, European heart journal.

[20]  K. Pacak,et al.  Adverse Drug Reactions in Patients with Phaeochromocytoma , 2007, Drug safety.